Vik Chopra

Stock Analyst at Wells Fargo

(3.68)
# 758
Out of 5,142 analysts
63
Total ratings
55.56%
Success rate
8.44%
Average return

Stocks Rated by Vik Chopra

Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190$180
Current: $175.10
Upside: +2.80%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21$26
Current: $29.12
Upside: -10.71%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181$200
Current: $190.02
Upside: +5.25%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41$42
Current: $45.14
Upside: -6.96%
Globus Medical
Nov 7, 2025
Maintains: Overweight
Price Target: $66$79
Current: $90.59
Upside: -12.79%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41$42
Current: $22.73
Upside: +84.78%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $15$12
Current: $12.54
Upside: -4.31%
NeuroPace
Nov 5, 2025
Maintains: Overweight
Price Target: $15$16
Current: $14.34
Upside: +11.58%
Henry Schein
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $70$76
Current: $79.57
Upside: -4.49%
Alphatec Holdings
Oct 16, 2025
Maintains: Overweight
Price Target: $14$16
Current: $13.01
Upside: +22.98%
Maintains: Equal-Weight
Price Target: $79$82
Current: $72.94
Upside: +12.42%
Maintains: Equal-Weight
Price Target: $25$13
Current: $12.21
Upside: +6.47%